What does BioPQQ (Pyrroloquinoline Quinone) do?

Antioxidant compound with early evidence for modest cognitive and blood flow benefits in older adults.

Is BioPQQ (Pyrroloquinoline Quinone) safe?

All human trials are very small (20–41 participants) and conducted by researchers with apparent ties to the BioPQQ manufacturer — independent replication is lacking

BioPQQ (Pyrroloquinoline Quinone) - Science-Based Research

What the Science Says

BioPQQ is a trademarked form of pyrroloquinoline quinone (PQQ), a naturally occurring antioxidant compound first identified in bacteria. Small clinical trials in healthy adults aged 50–70 suggest that 20 mg daily for 12 weeks may modestly improve attention and working memory, and increase blood flow and oxygen use in the prefrontal cortex — the brain region tied to focus and decision-making. One small trial also found a significant reduction in LDL cholesterol in participants who started with elevated levels, though triglycerides were unaffected.

What It Doesn't Do

Not proven to reverse dementia or treat any cognitive disease. No evidence it boosts energy like a stimulant. The cholesterol effect is preliminary and based on a tiny subgroup — don't replace your statin with this. No data showing it builds muscle, burns fat, or extends lifespan in humans. Animal studies showing dramatic effects haven't been replicated at scale in people.

Evidence-Based Benefits

BioPQQ is a trademarked form of pyrroloquinoline quinone (PQQ), a naturally occurring antioxidant compound first identified in bacteria. Small clinical trials in healthy adults aged 50–70 suggest that 20 mg daily for 12 weeks may modestly improve attention and working memory, and increase blood flow and oxygen use in the prefrontal cortex — the brain region tied to focus and decision-making. One small trial also found a significant reduction in LDL cholesterol in participants who started with elevated levels, though triglycerides were unaffected.

Weak Evidence

Effective at: 20 mg daily based on study doses

Source: auto-research

Absorption & Bioavailability

Unknown from provided studies — no pharmacokinetic data was reported in the human trials. The compound is water-soluble, which generally supports absorption, but human bioavailability data is not available from the provided papers.

Red Flags to Watch For

All human trials are very small (20–41 participants) and conducted by researchers with apparent ties to the BioPQQ manufacturer — independent replication is lacking
Rat toxicity studies showed kidney damage in females at high doses, and some in vitro tests showed weak chromosomal aberration signals (though in vivo genotoxicity tests were negative)
The cognitive benefits observed were modest and measured on narrow tests — real-world impact on memory or brain health is unclear
319 supplement products contain this ingredient despite very limited human evidence — widespread commercial use is far ahead of the science
No long-term human safety data beyond 12 weeks is available from the provided studies

Research Sources

PubMed
NIH DSLD